Expression of APOBEC3G/3F and G-to-A hypermutation levels in HIV-1-infected children with different profiles of disease progression.

Increasing evidence has accumulated showing the role of APOBEC3G (A3G) and 3F (A3F) in the control of HIV-1 replication and disease progression in humans. However, very few studies have been conducted in HIV-infected children. Here, we analyzed the levels of A3G and A3F expression and induced G-to-A...

Full description

Bibliographic Details
Main Authors: Nívea D Amoêdo, Adriana O Afonso, Sílvia M Cunha, Ricardo H Oliveira, Elizabeth S Machado, Marcelo A Soares
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3163681?pdf=render
_version_ 1818201697746419712
author Nívea D Amoêdo
Adriana O Afonso
Sílvia M Cunha
Ricardo H Oliveira
Elizabeth S Machado
Marcelo A Soares
author_facet Nívea D Amoêdo
Adriana O Afonso
Sílvia M Cunha
Ricardo H Oliveira
Elizabeth S Machado
Marcelo A Soares
author_sort Nívea D Amoêdo
collection DOAJ
description Increasing evidence has accumulated showing the role of APOBEC3G (A3G) and 3F (A3F) in the control of HIV-1 replication and disease progression in humans. However, very few studies have been conducted in HIV-infected children. Here, we analyzed the levels of A3G and A3F expression and induced G-to-A hypermutation in a group of children with distinct profiles of disease progression.Perinatally HIV-infected children were classified as progressors or long-term non-progressors according to criteria based on HIV viral load and CD4 T-cell counts over time. A group of uninfected control children were also enrolled in the study. PBMC proviral DNA was assessed for G-to-A hypermutation, whereas A3G and A3F mRNA were isolated and quantified through TaqMan® real-time PCR. No correlation was observed between disease progression and A3G/A3F expression or hypermutation levels. Although all children analyzed showed higher expression levels of A3G compared to A3F (an average fold of 5 times), a surprisingly high A3F-related hypermutation rate was evidenced in the cohort, irrespective of the child's disease progression profile.Our results contribute to the current controversy as to whether HIV disease progression is related to A3G/A3F enzymatic activity. To our knowledge, this is the first study analyzing A3G/F expression in HIV-infected children, and it may pave the way to a better understanding of the host factors governing HIV disease in the pediatric setting.
first_indexed 2024-12-12T02:57:41Z
format Article
id doaj.art-7ae76785748e43e88cec25077cc572c7
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-12T02:57:41Z
publishDate 2011-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-7ae76785748e43e88cec25077cc572c72022-12-22T00:40:42ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-0168e2411810.1371/journal.pone.0024118Expression of APOBEC3G/3F and G-to-A hypermutation levels in HIV-1-infected children with different profiles of disease progression.Nívea D AmoêdoAdriana O AfonsoSílvia M CunhaRicardo H OliveiraElizabeth S MachadoMarcelo A SoaresIncreasing evidence has accumulated showing the role of APOBEC3G (A3G) and 3F (A3F) in the control of HIV-1 replication and disease progression in humans. However, very few studies have been conducted in HIV-infected children. Here, we analyzed the levels of A3G and A3F expression and induced G-to-A hypermutation in a group of children with distinct profiles of disease progression.Perinatally HIV-infected children were classified as progressors or long-term non-progressors according to criteria based on HIV viral load and CD4 T-cell counts over time. A group of uninfected control children were also enrolled in the study. PBMC proviral DNA was assessed for G-to-A hypermutation, whereas A3G and A3F mRNA were isolated and quantified through TaqMan® real-time PCR. No correlation was observed between disease progression and A3G/A3F expression or hypermutation levels. Although all children analyzed showed higher expression levels of A3G compared to A3F (an average fold of 5 times), a surprisingly high A3F-related hypermutation rate was evidenced in the cohort, irrespective of the child's disease progression profile.Our results contribute to the current controversy as to whether HIV disease progression is related to A3G/A3F enzymatic activity. To our knowledge, this is the first study analyzing A3G/F expression in HIV-infected children, and it may pave the way to a better understanding of the host factors governing HIV disease in the pediatric setting.http://europepmc.org/articles/PMC3163681?pdf=render
spellingShingle Nívea D Amoêdo
Adriana O Afonso
Sílvia M Cunha
Ricardo H Oliveira
Elizabeth S Machado
Marcelo A Soares
Expression of APOBEC3G/3F and G-to-A hypermutation levels in HIV-1-infected children with different profiles of disease progression.
PLoS ONE
title Expression of APOBEC3G/3F and G-to-A hypermutation levels in HIV-1-infected children with different profiles of disease progression.
title_full Expression of APOBEC3G/3F and G-to-A hypermutation levels in HIV-1-infected children with different profiles of disease progression.
title_fullStr Expression of APOBEC3G/3F and G-to-A hypermutation levels in HIV-1-infected children with different profiles of disease progression.
title_full_unstemmed Expression of APOBEC3G/3F and G-to-A hypermutation levels in HIV-1-infected children with different profiles of disease progression.
title_short Expression of APOBEC3G/3F and G-to-A hypermutation levels in HIV-1-infected children with different profiles of disease progression.
title_sort expression of apobec3g 3f and g to a hypermutation levels in hiv 1 infected children with different profiles of disease progression
url http://europepmc.org/articles/PMC3163681?pdf=render
work_keys_str_mv AT niveadamoedo expressionofapobec3g3fandgtoahypermutationlevelsinhiv1infectedchildrenwithdifferentprofilesofdiseaseprogression
AT adrianaoafonso expressionofapobec3g3fandgtoahypermutationlevelsinhiv1infectedchildrenwithdifferentprofilesofdiseaseprogression
AT silviamcunha expressionofapobec3g3fandgtoahypermutationlevelsinhiv1infectedchildrenwithdifferentprofilesofdiseaseprogression
AT ricardoholiveira expressionofapobec3g3fandgtoahypermutationlevelsinhiv1infectedchildrenwithdifferentprofilesofdiseaseprogression
AT elizabethsmachado expressionofapobec3g3fandgtoahypermutationlevelsinhiv1infectedchildrenwithdifferentprofilesofdiseaseprogression
AT marceloasoares expressionofapobec3g3fandgtoahypermutationlevelsinhiv1infectedchildrenwithdifferentprofilesofdiseaseprogression